| SARS-CoV-2 viral load is associated with increased disease severity and mortality J Fajnzylber, J Regan, K Coxen, H Corry, C Wong, A Rosenthal, D Worrall, ... Nature communications 11 (1), 5493, 2020 | 956* | 2020 |
| Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic AG Edlow, JZ Li, YC Ai-ris, C Atyeo, KE James, AA Boatin, KJ Gray, ... JAMA network open 3 (12), e2030455-e2030455, 2020 | 451 | 2020 |
| The control of HIV after antiretroviral medication pause (CHAMP) study: posttreatment controllers identified from 14 clinical studies G Namazi, JM Fajnzylber, E Aga, RJ Bosch, EP Acosta, R Sharaf, ... The Journal of infectious diseases 218 (12), 1954-1963, 2018 | 188 | 2018 |
| An enhanced isothermal amplification assay for viral detection J Qian, SA Boswell, C Chidley, Z Lu, ME Pettit, BL Gaudio, JM Fajnzylber, ... Nature Communications 11 (1), 5920, 2020 | 154 | 2020 |
| Liver fibrosis index FIB‐4 is associated with mortality in COVID‐19 Y Li, J Regan, J Fajnzylber, K Coxen, H Corry, C Wong, A Rosenthal, ... Hepatology communications 5 (3), 434-445, 2021 | 68 | 2021 |
| The allosteric site on SHP2’s protein tyrosine phosphatase domain is targetable with druglike small molecules B Marsh-Armstrong, JM Fajnzylber, S Korntner, BA Plaman, AC Bishop ACS omega 3 (11), 15763-15770, 2018 | 30 | 2018 |
| Increased prevalence of myocardial injury in patients with SARS-CoV-2 viremia HK Siddiqi, B Weber, G Zhou, J Regan, J Fajnzylber, K Coxen, H Corry, ... The American Journal of Medicine 134 (4), 542-546, 2021 | 25 | 2021 |
| No significant changes to residual viremia after switch to dolutegravir and lamivudine in a randomized trial JZ Li, PE Sax, VC Marconi, J Fajnzylber, B Berzins, AN Nyaku, ... Open forum infectious diseases 6 (3), ofz056, 2019 | 25 | 2019 |
| Viral and host mediators of non-suppressible HIV-1 viremia A Mohammadi, B Etemad, X Zhang, Y Li, GJ Bedwell, R Sharaf, A Kittilson, ... Nature Medicine 29 (12), 3212-3223, 2023 | 24 | 2023 |
| Viral load kinetics of severe acute respiratory syndrome coronavirus 2 in hospitalized individuals with coronavirus disease 2019 J Regan, JP Flynn, A Rosenthal, H Jordan, Y Li, R Chishti, F Giguel, ... Open Forum Infectious Diseases 8 (8), ofab153, 2021 | 21 | 2021 |
| Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria J Fajnzylber, R Sharaf, JN Hutchinson, E Aga, RJ Bosch, W Hartogensis, ... Aids 35 (13), 2225-2227, 2021 | 13 | 2021 |
| Viral rebound kinetics correlate with distinct HIV antibody features YC Bartsch, C Loos, E Rossignol, JM Fajnzylber, D Yuan, A Avihingsanon, ... Mbio 12 (2), 10.1128/mbio. 00170-21, 2021 | 12 | 2021 |
| Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses X Sun, C Gao, K Zhao, Y Yang, Y Rassadkina, J Fajnzylber, J Regan, ... Frontiers in Immunology 13, 984553, 2022 | 10 | 2022 |
| Mean Coronary Cross‐Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIV AT Werede, JG Terry, S Nair, TM Temu, BE Shepherd, SS Bailin, ... Journal of the American Heart Association 11 (23), e025768, 2022 | 7 | 2022 |
| The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy Z Lone, A Zhang, T Benidir, D Corrigan, C Munoz-Lopez, P Hegde, ... Urologic Oncology: Seminars and Original Investigations 40 (10), 453. e1-453. e7, 2022 | 6 | 2022 |
| Cumulative ART exposure is associated with endothelial and immune activation in HIV J Castillo-Mancilla, S MaWhinney, RP Coyle, J Morrison, E Poeschla, ... Poster presented at: CROI, 4-8, 2019 | 4 | 2019 |
| Comparing pathologic and survival outcomes between primary and secondary muscle invasive bladder cancer when treated by radical cystectomy with or without neoadjuvant chemotherapy T Benidir, Z Lone, A Zhang, AS Nowacki, C Munoz-Lopez, P Hegde, ... Urology 168, 137-142, 2022 | 2 | 2022 |
| Diagnostic prediction models to identify patients at risk for healthcare-facility–onset Clostridioides difficile: A systematic review of methodology and reporting WM Patterson, J Fajnzylber, N Nero, AV Hernandez, A Deshpande Infection Control & Hospital Epidemiology 45 (2), 174-181, 2024 | | 2024 |
| Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection J Fajnzylber, WM Patterson, N Nero, AV Hernandez, A Deshpande Antimicrobial Stewardship & Healthcare Epidemiology 4 (1), e202, 2024 | | 2024 |
| Probiotics for primary prevention of Clostridioides difficile infection: revisiting the evidence J Fajnzylber, W Patterson, A Deshpande Current Medical Research and Opinion 39 (6), 889-891, 2023 | | 2023 |